HGCSG 1403: Phase I trial of oxaliplatin/irinotecan/S-1 (OX-IRIS) as first line chemotherapy for unresectable pancreatic cancer

Autor:	Satoshi Yuki, Yasuyuki Kawamoto, Shintaro Nakano, Tetsuhito Muranaka, Kazuteru Hatanaka, A. Yoshikawa, Yasuo Komatsu, Kentaro Sawada, Nobuhiko Abe, R. Saito, Hiroshi Nakatsumi, Naoya Sakamoto, Yoshimitsu Kobayashi, N. Ehira, Takuto Miyagishima, Ichiro Iwanaga, Y. Sakata, Kazuaki Harada, Atsushi Ishiguro, T. Saiki
Rok vydání:	2018
Předmět:	Oncology Irinotecan/S-1 Unresectable Pancreatic Cancer medicine.medical_specialty business.industry Hematology Oxaliplatin medicine.anatomical_structure Internal medicine medicine First line chemotherapy Iris (anatomy) business medicine.drug
Zdroj:	Annals of Oncology. 29:v38-v39
ISSN:	0923-7534
DOI:	10.1093/annonc/mdy151.138
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::1508f66f56e7967d2e83056afee23e75 https://doi.org/10.1093/annonc/mdy151.138 Zobrazit plný text záznamu